GlaxoSmithKline, which makes the rival flu drug Relenza, said there was no indication influenza viruses were resistant to its drug. Relenza, known generically as zanamivir, is squirted into the nose and is used even less commonly than Tamiflu.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.